Importantly, we found that IGF-1, PI3K(p85α) and the downstream (from IGF-1) effectors were all decreased in the in vitro muscle atrophy models and miR-29b agomir could decrease them in vivo, providing some insights of their potential roles in muscle atrophy in vivo. The gene discussed is IGF1; the disease is muscle atrophy.